With direct, hands-on management experience working with executive management, P&L management, strategic planning, mergers and acquisitions, and organizational optimization, Brandon Cormier brings diverse business experience to his role as Elligo’s chief commercial officer. He has a long history of exceeding sales goals and nurturing relationships that support a company’s growth.
Cormier’s nearly 20-year career has been focused in the life sciences. Before Elligo, he held various business development roles of increasing responsibility at Syneos Health, Ventana Clinical Research, INC Research, GlaxoSmithKline, and DuPont Pharma. Cormier was also a member of the board of directors for INC Research Canada, and received Bachelor of Science degrees in biology and economics from the University of Toronto.